The global clot management devices market is expected to grow from USD 2.03 billion in 2020 to USD 3.32 billion by 2028, at a CAGR of 5.58% during the forecast period 2021-2028.
A blood clot prevents blood from reaching the lungs, heart, legs and brain. Heart attacks, strokes, and extreme leg pain are all caused by blood clots that develop in the arteries. In addition, the formation of blood clots is a leading cause of death in cancer patients. Anticoagulation surgery and medications are used to treat blood clots. Neurovascular, arteriovenous, periphery artery, and coronary thrombosis are also treated with clot management equipment. Due to the increasing prevalence of peripheral artery syndrome, clot control devices are being used more frequently.The increase in the prevalence of kidney and coronary heart diseases, as well as the ageing population, are some of the major factors driving the global clot management devices market forward. In addition, growing healthcare awareness is fueling the demand for clot management products. Nonetheless, in developing countries, a scarcity of trained physicians and low pay are major roadblocks to the growth of the global clot management devices sector. Furthermore, since anticoagulant therapy is the main treatment for deep vein thrombosis, the demand for clot management devices is hindered.
This study delivers a comprehensive analysis of products, end-users and regions.The product segment includesInferior Vena Cava Filters (IVCF), Percutaneous Thrombectomy Devices, Neurovascular Embolectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Embolectomy Balloon Catheters. The neurovascular embolectomy devices segment is anticipated to show the highest share of 22.56% over the forecast period. Over the forecast period, this segment is expected to grow due to rising demand for cost-effective products, continued investments in research and development, and improvements in the health of the patient.The end-user segment includes hospitals and diagnostic centers. Hospitals had the highest share of 58.35% in 2020 in the clot management devices market. The methods for removing clots pose a significant risk to patients. In the majority of stroke cases, patients are transferred to critical care units or emergency services, which are completely equipped with the required framework for high-tech operations. Furthermore, the payment conditions for a patient-administered in the hospital's emergency room vary from those for diagnostic centres and ambulatory care.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The Asia Pacific is anticipated to show the highest share of 23.88% in the market over the forecast period. Diabetes, obesity, and cardiovascular diseases are on the rise in countries like China and India, owing to demographic trends, lifestyle changes, and increased disposable income. During the forecast period, the rising prevalence of target disorders, combined with improved healthcare infrastructure and the launch of technologically superior products, is expected to drive demand for clot management devices.
Some of the notable players in the global clot management devices market areBoston Scientific Corporation, Medtronic, Inc., AngioDynamics, Inc., Bayer HealthCare AG, Janssen Pharmaceuticals, Inc., Applied Medical Resources Corporation, Volcano Corporation, Stryker Corporation, EKOS Corporation and Edwards Lifesciences Corporation.
This study forecasts revenue growth at global, regional, and country levels from 2021 to 2028. Fior Markets has segmented the market based on below-mentioned segments:
Global Clot Management Devices Market Analysis And Forecast, By Product
Global Clot Management Devices Market Analysis And Forecast, By End-User
Global Clot Management Devices Market Analysis And Forecast, By Regional Analysis
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Product
4.3.2. Market Attractiveness Analysis By End-User
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Increase in the number of patients suffering coronary heart disease, peripheral arterial disease, stroke, and venous thromboembolism
5.2.2. Rising demand for successful thrombectomy/embolectomy devices
5.2.3. Increased awareness of newer approaches to clot management
5.3. Restraints
5.3.1. Shortage of qualified physicians and low pay in developing countries
5.4. Opportunities
5.4.1. Combined use of catheter guided thrombolysis and percutaneous thrombectomy for the treatment of acute venous thrombosis
5.5. Challenges
5.5.1. Complications in system handling
6. Global Clot Management Devices Market Analysis and Forecast, By Product
6.1. Segment Overview
6.2. Inferior Vena Cava Filters (IVCF)
6.3. Percutaneous Thrombectomy Devices
6.4. Neurovascular Embolectomy Devices
6.5. Catheter-Directed Thrombolysis (CDT) Devices
6.6. Embolectomy Balloon Catheters
7. Global Clot Management Devices MarketAnalysis and Forecast, By End-User
7.1. Segment Overview
7.2. Hospitals
7.3. Diagnostic Centers
8. Global Clot Management Devices MarketAnalysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Clot Management Devices Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Clot Management Devices Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Boston Scientific Corporation
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Medtronic, Inc.
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. AngioDynamics, Inc.
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Bayer HealthCare AG
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Janssen Pharmaceuticals, Inc.
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Applied Medical Resources Corporation
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Volcano Corporation
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Stryker Corporation
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. EKOS Corporation
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Edwards Lifesciences Corporation
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
List of Table
1. Global Clot Management Devices Market, By Product, 2018-2028(USD Billion)
2. Global Inferior Vena Cava Filters (IVCF), Clot Management DevicesMarket, By Region, 2018-2028(USD Billion)
3. Global Percutaneous Thrombectomy Devices, Clot Management Devices Market, By Region, 2018-2028(USD Billion)
4. Global Neurovascular Embolectomy Devices, Clot Management Devices Market, By Region, 2018-2028 (USD Billion)
5. Global Catheter-Directed Thrombolysis (CDT) Devices, Clot Management Devices Market, By Region, 2018-2028 (USD Billion)
6. Global Embolectomy Balloon Catheters, Clot Management Devices Market, By Region, 2018-2028 (USD Billion)
7. Global Clot Management Devices Market, ByEnd-User, 2018-2028(USD Billion)
8. Global Hospitals, Clot Management Devices Market, By Region, 2018-2028(USD Billion)
9. Global Diagnostic Centers, Clot Management Devices Market, By Region, 2018-2028(USD Billion)
10. North America Clot Management Devices Market, By Product, 2018-2028(USD Billion)
11. North America Clot Management Devices Market, ByEnd-User, 2018-2028(USD Billion)
12. U.S. Clot Management Devices Market, By Product, 2018-2028(USD Billion)
13. U.S. Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
14. Canada Clot Management Devices Market, By Product, 2018-2028(USD Billion)
15. Canada Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
16. Mexico Clot Management Devices Market, By Product, 2018-2028(USD Billion)
17. Mexico Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
18. Europe Clot Management Devices Market, By Product, 2018-2028(USD Billion)
19. Europe Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
20. Germany Clot Management Devices Market, By Product, 2018-2028(USD Billion)
21. Germany Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
22. France Clot Management Devices Market, By Product, 2018-2028(USD Billion)
23. France Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
24. U.K. Clot Management Devices Market, By Product, 2018-2028(USD Billion)
25. U.K. Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
26. Italy Clot Management Devices Market, By Product, 2018-2028(USD Billion)
27. Italy Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
28. Spain Clot Management Devices Market, By Product, 2018-2028(USD Billion)
29. Spain Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
30. Asia Pacific Clot Management Devices Market, By Product, 2018-2028(USD Billion)
31. Asia Pacific Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
32. Japan Clot Management Devices Market, By Product, 2018-2028(USD Billion)
33. Japan Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
34. China Clot Management Devices Market, By Product, 2018-2028(USD Billion)
35. China Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
36. India Clot Management Devices Market, By Product, 2018-2028(USD Billion)
37. India Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
38. South America Clot Management Devices Market, By Product, 2018-2028(USD Billion)
39. South America Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
40. Brazil Clot Management Devices Market, By Product, 2018-2028(USD Billion)
41. Brazil Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
42. Middle East and Africa Clot Management Devices Market, By Product, 2018-2028(USD Billion)
43. Middle East and Africa Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
44. UAE Clot Management DevicesMarket, By Product, 2018-2028(USD Billion)
45. UAE Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
46. South Africa Clot Management Devices Market, By Product, 2018-2028(USD Billion)
47. South Africa Clot Management Devices Market, By End-User, 2018-2028(USD Billion)
List of Figures
1. Global Clot Management Devices Market Segmentation
2. Global Clot Management Devices Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Clot Management Devices Market Attractiveness Analysis By Product
9. Global Clot Management Devices Market Attractiveness Analysis By End-User
10. Global Clot Management Devices Market Attractiveness Analysis By Region
11. Global Clot Management Devices Market: Dynamics
12. Global Clot Management Devices Market Share by Product(2021&2028)
13. Global Clot Management Devices Market Share by End-User (2021&2028)
14. Global Clot Management Devices Market Share by Regions (2021&2028)
15. Global Clot Management Devices Market Share by Company (2020)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.